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C4 is the only component of the human complement system that is coded for by
two genes, C4A and C4B, showing 99% homology. The genes for the two C4 iso-
types arelocated with the genes for the second component (C2), factorB (BF), and
steroid21-hydroxylase (21-OHA and 21-OHB)between HLA-B and-DR in theMHC
onchromosome six (1-4) . The C4 and21-OH genes aretandemly arranged and have
probably arisen by duplication (Fig . 1 a) . Based on the direction of transcription,
C4A is usually expressed atC4 locus I, whereas C4B is usually expressed at locus II (5) .
C4A and C4B are highly polymorphic with more than 35 alleles including null
alleles (C4QO) at both loci (6) . Thepolymorphism can be defined by electrophoretic
mobility ofthe intact protein or its subunits (7-9), by serology of Rodgers (Rg) and
Chido (Ch) determinants (10), and by functional studies of complement activation
and binding characteristics (11, 12). A sequence of four amino acids in the C4d re-
gion (Chido 4 determinant on C4B molecules) is responsible for the major struc-
tural andfunctional differences of the C4 isotypes (Fig . 1 c ; 9, 11-13) . The antigenic
determinants Rodgers and Chido are generally expressed on theC4A andC4B iso-
types, respectively, but rare reversed associations have been described (14) . Gene
conversion has been discussed as a possible mechanism for the generation of aber-
rant allotypes (15, 16) .
Null alleles of C4A or C4B (AQO or BQO) occur at frequencies of 0.1-0.3 in the
normal population (17), and are assessed by the absenceofgene products . The struc-
tural analysis of the C4 genes at theDNA level has revealed that only a proportion
ofC4 null alleles result from gene deletions affecting an entire C4 gene and oneadja-
cent 21-OHgene, and consequently other null alleles were dueto nonexpressed genes
(pseudogenes) (18, 19) . Alternatively, it hasbeen suggested that null alleles represent
the expression of two identical, andtherefore undistinguishable, allotypesonahaplo-
type, and this results from gene conversion of C4A to C4B and the reverse (5, 20) .
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Haplotypeswith the typical C4 two-gene configuration expressing two different C4A
allotypes (e.g., C4A3,2 BQO), as well as a single C4A3 BQO haplotype with two C4
loci only containing specific sequences ofthe C4A isotype, have already been reported
(5, 20-22).
To further characterize the structural basis of C4 null alleles not accounted for
by deletions, we studied 26 individuals homozygouseither for C4AQOor for C4BQO.
Haplotypes carrying null alleles not due to deletions were selected for studyby genomic
RFLP analysis. Using synthetic oligonucleotides, restriction fragment analysis, and
direct sequencingof genomic DNA amplified by the polymerase chain reaction (23,
24), we studied the isotype-specific sequences of the C4d region that correlate with
the Rodgers and Chido determinants as defined by serology. The presence of a respec-
tive DNA sequence for a given determinant not detectable by serology would indi-
cate the nonexpression of an allele, whereas the correlation of DNA sequence and
serological findings would provide evidence for the possible expression ofboth adja-
cent C4 genes. Using this approach, we detected six haplotypes in which C4A genes
were nonexpressed and 19 haplotypes with apparent nondeleted BQO alleles which
had only C4A-specific sequences. These findings provide evidence for independent
genetic mechanisms at the C4 loci resulting either in pseudogenes or in genes which,
as a result of gene conversion, may express the reverse isotype.
Materials and Methods
Selection of Individuals and Genetic Typing .
￿
26 individuals with homozygous C4A or C4B
deficiency (AQO or BQO) were included. All individuals had been haplotyped for MHC class
I, II, and III gene products in family studies according to the following methods: HLA-A,
-B, -C, and -DR antigens were assigned by the microlymphocytotoxicity assay (25). C4 typing
was carried out by high voltage agarose gel electrophoresis in a discontinuous buffer system
after desialation of the samples with neuraminidase, followed by immunofixation or hemo-
lytic overlay (7). C4 null alleles were confirmed by C4 a chain typing usingSDS-PAGE (9).
The serological typing ofthe C4 antigenic determinants Rodgers and Chido was carried out




The C4-specific probe used for Southern blot analysis was a 400-bp Barn
HI/Kpn I fragment from the Tend of the full-length C4 cDNA clone pATA (26), and the




Human genomic DNA was prepared from 10-ml blood samples
(27). DNA samples of 10 t~g were digested with Taq I at a concentration of 5 U/lig (Boehringer
Mannheim, Mannheim, FRG). The DNA fragments were electrophoresed in a 0.8% agarose
gel and blotted onto nitrocellulose membrane (BA 85; Schleicher & Schuell, Dassel, FRG).
The C4 and 21-OH probes were radiolabeled with a-[32P]dCTP (Amersham Buchler,
Braunschweig, FRG) by nick translation. Hybridization of blots and interpretation of re-
striction fragment patterns were carried out as described previously (19).
PCRAmplification.
￿
The polymerasechain reaction was performed as described (24) using
1 ttg genomic DNA and 2 U Taq polymerase (Cetus Corp., Emeryville, CA). The tempera-
ture cycles were modified as follows and repeated 35 times: 2 min at 91°C (denaturing), 3
min at 55°C (annealing), 5 min at 70°C (extension).
The primer sequences were chosen according to published C4 gene sequences (28). The
four oligonucleotide primers were as follows (cf., Figs. 1 b and 2 a): L-1, 5'-TGAGTTTGG-
CCCAGGAGCAG-3; L-2, 5'-TGCCACAGTCTCATCATTGC-3'; L-3, 5'-TGCGGATCC-
AGCAGTTTCGGAAG-3'; L-4, 5'-ATAGGATCCTAAGGTCCCCTGGGCCT3' With these
primers, the C4d regions of all C4 (A and B) genes present in an individual are amplified.
Detection of C4 Isotype-specific Sequences.
￿
For oligonucleotide hybridization (Fig. 1), theBRAUN ET AL.
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amplified DNA was electrophoresed in a 1% agarose gel. After transfer to nylon membrane
(Hybond N; Amersham Buehler), the blots were hybridized first with oligo A according to
procedures described previously (29). After autoradiography for 6 h, the probe was removed
by boiling the blots for 20 min in 0.1% SDS and rehybridized with oligo B. Oligos A and B
were endlabeled with polynucleotide kinase (Boehringer Mannheim) with y-[32p]ATP (Am-
ersham Buchler).
For the direct analysis of restriction fragments (Fig. 2), the amplified DNA (using PCR
primers (L3/L4) was purified from PCR buffer components by adsorption to glass milk
(Geneclean; BIO 101; La Jolla, CA), and digested with 5 U EcoO 109, with 3 U Nla IV,
or with 10 U Alu I (all from New England Biolabs, Bad Schwalbach, FRG). DNA digested
with Nla IV and EcoO 109 was electrophoresed in a 1.5% agarose gel. DNA digested with
Alu I was separated in a 10% polyacrylamide gel, as the resulting fragments were smaller




For direct sequencing of PCRamplified genomic DNA, the amplified
DNA fragment was purified by agarose gel electrophoresis followed by electroelution to re-
move the PCR primers. The eluted template DNA was further purified by adsorption to glass
milk (see above). The sequencing reaction was carried out following a protocol for double-
stranded DNA with the SequenaseTM sequencing system (United States Biochemical Corp.,
Cleveland, OH) and a-[35S]dATP (Amersham Buchler). As sequencing primers, the fol-
lowing oligonucleotides were used: L-3 ; L-4 (see above); L-5, 5'-TGTTGAAGGTCCTGAGT
3'; and L-6, 5'TTTGGTGGGCAATGATG-3' (28).
Results and Discussion
To identify carriers ofnondeleted AQOand BQOalleles, we determined the C4 gene
structure by Southern blot analysis of Taq I-digested DNA (not shown). Four Taq
I fragments can be identified with the 5'C4 probe. A 7-kb fragment usually represents
a C4A gene at locus I, whereas the 6- and 5 .4-kb fragments identify long and short
genes at locus II; these are usually C4B. A 6.4-kb fragment represents a short C4B
gene in combination with a deletion of the C4A gene, whereas C4B gene deletions
are detected on the assessment of different intensities of the C4A- and CO-specific
DNA fragments (19). Two smaller Taq I fragments are detected with the 21-OH-specific
probe. A 3.2-kb fragment represents a 21-OHA gene and a 3.7-kb fragment a 21-
OHB gene (30). All haplotypes with C4 gene deletions are listed in Table I. In 5
of 11 AQOindividuals both C4A genes were deleted, whereas in 6 only one C4A gene
was deleted and the other was present. 2 of 15 BQO individuals had both C4B genes
deleted, 7 had one gene deleted, and in 6 neither was deleted. 10 of 16 C4A gene
deletions were linked to the extended MHC haplotype HLA-Al, Cw7, B8, DR3,
C4AQOB1, whereas no characteristic haplotypes were found to be linked with C4B
gene deletions (Table I). 19 individuals with 25 haplotypes carrying nondeleted null
alleles, 6 AQO and 19 BQO, were selected for the study.
The antigenic determinant Ch4 is present on all C4B molecules and therefore
defines the C4B isotype. Oligonucleotides (oligo A, oligo B; Fig. 1 c), capable of
distinguishing the isotype-specific Ch4 sequence at the DNA level, were used to screen
nondeleted C4 null alleles. As hybridization of these oligonucleotides to genomic
Southern blots did not give satisfactory results, we used PCR with subsequent oligo-
nucleotide hybridization (Fig. 1). A 258-bp sequence of the Cod region containing
the five isotype-specific base substitutions was amplified with primers LI and L2
(Fig. 1, b-c). Under the given hybridization conditions, the C4A and C4B isotype-
specific 23-mers hybridized exclusively with the respective C4d sequence (cf., con-132
￿
NULL ALLELES OF HUMAN COMPLEMENT C4
" -, A deletion of the respective gene .
TABLE I
Haplotypes with C4 Gene Deletions
FIGURE 1.
￿
(a) Map ofthe tandemly arranged C4 and 21-hydroxylase genes of the MHC class III
region . The orientation relative to HLA-B and -DR is shown . The hatched areas within the C4
genes depict the location of the polymorphic Cod regions. (b) Strategy for PCR amplification
ofthe C4d isotype-specific sequence . The positions of polymorphic nucleotides are indicated by
x (26) . (c) Oligonucleotide sequences A and B used to detect the isotype-specific sequences of
the C4 genes . The isotypic nucleotide positions and amino acid residues are indicated by bold
characters and bars . (d) Examples for hybridization of oligos A and B with amplified 258-bp
fragment ofhomozygous C4AQO (lane 5) and C4BQO individuals (lanes 1-4, 6) with at least one
nondeleted C4QO allele. ControlsA and B represent amplifiedDNA from genomic cosmid clones
cos 3A3 (C4A gene) andKEM-1 (C4B gene) (gift of Dr.M . C. Carroll, Harvard Medical School,
Boston, MA) .
HLA-






C4B 21-OHB No .
kb
A . C4A/21-OHA Deletions :
1 w7 8 3 QO 1 -` - 6 .4 3 .7 (10)
1 8 2 QO 1 - - 6 .4 3 .7 (1)
1 8 4 QO 1 - - 6 .4 3 .7 (1)
1 8 5 QO 3 - - 6 .4 3.7 (1)
1 w2 35 3 QO 1 - - 6 .4 3 .7 (1)
1 w70 3 QO 1 - - 6 .4 3 .7 (1)
3 w70 4 QO 1 - - 6.4 3 .7 (1)
B . 21-OHA/C4B Deletions :
24 8 1 3 QO 7.0 - - 3 .7 (1)
24 w5 18 3 3 QO 7.0 - - 3 .7 (1)
2 18 4 3 QO 7.0 - - 3 .7 (1)
24 w1 27 3 3 QO 7 .0 - - 3 .7 (1)
1 (11) w4 35 1 3 QO 7 .0 - - 3.7 (3)
2 w65 1 3 QO 7 .0 - - 3 .7 (1)
C . C4B/21-OHB Deletions :
3 w6 w47 7 1 QO 7.0 3.2 - - (1)
2 w60 w6
3 QO 7 .0 3.2 (1)BRAUN ET AL.
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trols A and B, Fig. 1 d). All six haplotypes carrying AQO alleles with expressed C4B
genes reacted with oligos A and B. In contrast, all 19 haplotypes with BQO alleles
and expressed C4A genes reacted with oligo A alone (Fig. 1 d; Table II).
Taq I fragments of 6.0 and 5.4 kb generally represent C4B genes at C4 locus II
(5, 19), but the nonhybridization of oligo B with genes at locus II suggested that
C4A sequenceswere present. This result could alsobe explained bypointmutations
or deletions in the Ch4 sequence not detectable by Southern blot analysis. There-
fore, we usedRFLPanalysis ofamplified DNAwith NlaIV, which alsodistinguishes
between C4A and C4Bgenes (reference 5; Fig. 2 a), and confirmed that all BQO indi-
viduals revealed only C4A-specific fragments (Fig. 2 b, Table II). In addition, the
Rgl- and Chl-specific DNA sequences, which can be distinguished by RFLP anal-
ysis with EcoO 109 (5; Fig. 2 a), also corroborated the data with oligos A and B.
All six haplotypes with AQO alleles revealed both the Rgl- and Chl-specific frag-
ments. All 19 haplotypes with BQO alleles had only the Rgl-specific fragment (Fig.
2 b, Table II). The plasma samples of all BQO individuals were tested for the pres-
ence of Rg/Ch determinants by serology, and in accordance with the DNA data,
Chl was absent from all BQO individuals (data not shown).
The determinant Ch6, which is normally expressed by C4B but also known on
C4A (14), was assessed on the protein and the DNA level as well. Amplified DNA
TABLE II
HLA Haplotypes, C4 Gene Structure and Rodgers/Chido Determinants of Nondeleted C4Q0 Alleles
Oligo
nt, not tested, as nonexpression has already been shown.
" Individual DNA heterozygous for Ch6, assignment to haplotype or gene not possible.
HLA alleles C4 alleles

















A. C4AQO B1 (2) haplotypes:
w60 w6 QO 1 7.0 5.4 + + + + nt (2)
w60 w6 QO 2 7.0 5 .4 + + + + nt (3)
w60 3 QO 2 7.0 5 .4 + + + + nt (1)
B. C4A3 BQO haplotypes:
44 4 3 QO 7.0 6.0 + - + - + - (4)
44 5 (w6) 3 QO 7.0 6.0 + - + - + - (2)
35 1 3 QO 7.0 6.0 + - + - " (3)
35 w6 3 QO 7 .0 6,0 + - + - " (1)
18 3 3 QO 7.0 6.0 + - + - (1)
39 4 3 QO 7.0 6.0 + - + - - + (1)
w60 1 3 QO 7.0 6.0 + - + - + - (1)
w70 w6 3 QO 7.0 6.0 + - + - (1)
C. C4A3,2 BQO haplotypes:
35 1 3,2 QO 7.0 6.0 + - + - - + (1)
35 1 3,2 QO 7.0 6.0 + - + - (1)
35 4 3,2 QO 7.0 6.0 + - + - - + (1)
w62 w6 3,2 QO 7.0 6.0 + - + - - + (1)
w62 1 3,2 QO 7.0 6.0 + - + - " (1)134
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FIGURE 2 .
￿
Legend on facing page .
from BQO individuals was digested with Alu I (Fig. 2, a, c) . The results were not
as uniform as for the Ch4 and Chl determinants . A number of heterozygotes were
detected at theDNA level (indicated by asterisk in Table II ; cf ., Fig . 2 c, lanes 1,
2), which did not allow the assignment of the Ch-6 andCh+6 sequences to one
of the haplotypes . SevenMHC haplotypes identified by linkage to HLA-B44 and
Bw601acked the sequence coding forCh6 at both C4 loci (Table II; Fig . 2 c, lanes
3, 5) . However, four haplotypes linked to HLA-B35, B39, and Bw62 had the se-
quence for Ch6 at both loci (Table II ; Fig. 2 c, lanes 4, 6). Again, these findings





(a) Strategy for the amplification and RFLP analysis of the 926-bp C4d fragment
to analyze the sequences coding for determinantsCM (Nla IV), Rgl/Chl (EcoO 109), and Ch6
(Alu I). The fragment sizes for each enzyme indicating the presence of C4A- or C4B-specific
sequences are given in the respective restrictionmaps (5, 26). (b) Examples for restriction frag-
ment analysis of PCRamplified DNA with Nla IV (CM ; 1efl) and EcoO 109 (Rgl/Chl ; right) .
Fragment sizes are indicated on both sides . The DNA fragment length standard (S) is Hae
III-digested PhiX 174 bacteriophageDNA. (Lanes 1, 2) DNAfrom C4BQ0individuals ; (lanes
3, 4) DNA from C4AQ0 individuals ; (lanesA, B) C4A, C4B controls (cf., Fig . 1 d) . (c) Examples
for restriction fragment analysis of PCRamplifiedDNAfrom C4BQ0individuals with Alu I (Ch6) .
Fragment sizes of genomic fragments are indicated on the left side with the polymorphic frag-
ments printed in italics, and sizes oftheDNAfragment length standard (as in Fig . 2 b) are given
on right side . (Lanes 1, 2) DNA from individuals with Ch-6 and Ch+6 sequences (marked
by asterisk in Table II), note the difference in fragment intensities between 60/70 by and 50/89
bp ; (lanes 3, 5)DNAfrom individuals withCh-6 sequence; (lanes 4, 6)DNAfrom individuals
with Ch+6 sequence ; (lanes A, B) C4A, C4B controls (cf., Fig . 1 d).
theDNA level, thedeterminants Rgl and 2 were present on theC4 molecules . When
theCH sequence was detected, only Rgl and Ch6 but not Rg2 were found by se-
rology (datanot shown) . This reversed antigenic association ofC4A alleleswith the
Ch6determinanthas alreadybeen described forseveral C4A allotypes (14) and thus
does not contradict our previous results .
For a single individualhomozygous forHLA-B44, C4A3 BQO, andwith four struc-
turally intact C4 genes we directly sequenced the relevant portions of the C4d re-
gion afterPCR amplification. We only detected sequences typical for theC4A iso-
type, i.e ., Ch-4 (Fig. 3 a), Rgl and Ch-6 (Fig. 3 b), thus confirming our results136
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FIGURE 3 .
￿
GenomicDNA sequence obtained afterPCR amplification withPCR primers L3/L4 .
TheDNA was selected from an individual homozygous for the haplotype HLA-B44, C4A3 BQO
and without gene deletions . The nucleotides typical for C4A are indicated and the alternative
C4B nucleotides are given in brackets . The numbers indicate the respective position within the
C4cDNA sequence.(28). (a) The sequence ofthe isotype-specific region correlated to Ch4/Ch-4
(coding strand) . (b) Top : The sequence correlated to the serological determinant Rgl/Chl (non-
coding strand) . Bottom : The sequence correlated to the serological determinant Ch6/Ch-6(Rg2)
(coding strand) .
obtained by oligonucleotidehybridizationandRFLP analysis . No ambiguous nucleo-
tide position was observed that would then indicate the presence of two different
isotypes .
The complete haplotypedata aresummarized in Table II . All sixAQO alleles were
found on haplotypes with HLA-Bw60 and a short C4B gene (16 kb), as indicated
by the 5.4-kb Taq I fragment (Table II A) . TheDNA analysis has revealed the pres-
ence of C4A-specific sequences not detectable at the protein level by SDS PAGE,
high voltage gel electrophoresis, andserology . We therefore conclude that these non-
deleted genes are C4A pseudogenes on these haplotypes . The structural basis of the
defect, which is not yet determined, may be due to point mutations or deletions,
similar to those already observed in the 3' adjacent 21-OHA pseudogene (31, 32).
These mutations may have occurred either in the coding sequence resulting in a
stop codon, or may have affected the sequences controlling the expression of the
C4A gene .
We have detected only C4A-specific sequences in BQO alleles . All the haplotypes
with BQO alleles had long C4 genes at both C4 loci, as defined by the 7 .0 and 6.0
kbTaq I fragments(Table II, B-C) . When C4A alleles at each locus ofonehaplotype
are identical, the individual gene products cannot be distinguished, e.g., C4A3, (A3)BRAUN ET AL.
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BQO (Table II B), and expression of the second locus cannot be proven. However,
the expression of "converted" locusII genes is detectable when the C4A allele is different
from that expressed by the accompanying C4A gene at locus I (5, 21, 22). If expres-
sion of the converted gene can be demonstrated conclusively, then it can no longer
be referred to as null allele. 6 of the 14 BQO haplotypes only expressing the C4A3
allotype carry the alleles for HLA-B44, DR4 (orDR5, DRw6) (Table II B). A single
similar haplotype has been detected previously by using genomic RFLP analysis
(5). The expression of two different CM alleles on the same haplotype canbe identified
only by segregation analysis in informative families. In five haplotypes, A3, A2 ex-
pression is considered probable and both genes carry C4A-specific sequences except
for the Ch6 determinant (Table II C).
Deletions and duplications of C4 genes leading to haplotypes with a single or three
C4 genes have been demonstrated by RFLP studies and some of these may be due
to a single unequal crossover event(18, 19). However, gene conversion has been sug-
gested as a mechanism for the aberrant C4A1 (Ch+) and C4B5 (Rg+) allooypps
(15, 16), which seems more acceptable than recombination by multiple crossover
events. Gene conversion maybe expected when two closely linked genes have arisen
by duplication and have a high degree of structural homology, as is the case forthe
C4A and C4B genes (1, 2, 26). Our data suggest that conversion has occurred only
at locus II (C4B). Recently, however, an individual has been describedwith a haplo-
type carrying two loci (a long and a short C4 gene) both expressing C4B isotypes
(C4AQO B1,5). This may serve as an example that a complete conversion at locus
I (C4A) is also possible, but obviously less common (33). As only six C4AQOhaplo-
types without C4A deletions were available for study and all of these are linked to
HLA-Bw60, they may have arisen from a single mutation. This could also be the
case for the six converted locus II genes carrying C4A-specific sequences, including
the Ch-6 sequence andlinked to HLA-B44. It remains to be shown, however, whether
these converted genes trulyexpress the C4A3 allotype. This canbe conclusively proven
only by cloningandexpressing the entire gene in transfected cells, as hasbeen demon-
strated for normal human C4 genes (34). Our approach to the study of C4 null al-
leles allows the rapid analysis of extensively typed individuals to further investigate
the molecular basis of C4 deficiency. At the same time the C4 gene region of the
MHC may serve as a model to study the complex genetic mechanism of gene con-
version.
Summary
The two genes for the C4A and C4B isotypes of the fourth component of human
complement arelocatedin the MHC class III region. Previous studies have demon-
strated the unusual expression of C4 genes in the form of aberrant or duplicated
haplotypes. Null alleles of C4A or C4B (AQO or BQO) have been defined by the ab-
sence of gene products and occur at frequencies of 0.1-0.3 . However, only some C4
null alleles are due to gene deletions, the remainderwere thoughtto be nonexpressed
genes. We have analyzed the C4 gene structureof 26 individuals lacking either C4A
or C4B protein. The DNA of individuals with apparently nonexpressed C4 genes
was tested for the presence of C4A- and C4B-specific sequences using restriction
fragment analysis and isotype-specific oligonucleotide hybridization ofDNAamplified138
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by polymerase chain reaction. All nondeletedAQO alleles had C4A-specific sequences
and may thus be described as pseudogenes, whereas the nondeleted BQOalleles had
C4A- instead of C4B-specific sequences. Gene conversion is the probable mecha-
nism by which a C4A gene is found at the second C4 locus normally occupied by
C4B genes.
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